FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045987911> ?p ?o ?g. }

• W2045987911 endingPage "69" @default.
• W2045987911 startingPage "60" @default.
• W2045987911 abstract "Abstract Chemotherapeutic resistance, particularly to doxorubicin (Dox), represents a major impediment to successfully treating breast cancer and is linked to elevated tumor metabolism and tumor over‐expression and/or activation of various families of receptor‐ and non‐receptor‐associated tyrosine kinases. Disruption of circadian time structure and suppression of nocturnal melatonin production by dim light exposure at night ( dLEN ), as occurs with shift work, and/or disturbed sleep–wake cycles, is associated with a significantly increased risk of an array of diseases, including breast cancer. Melatonin inhibits human breast cancer growth via mechanisms that include the suppression of tumor metabolism and inhibition of expression or phospho‐activation of the receptor kinases AKT and ERK 1/2 and various other kinases and transcription factors. We demonstrate in tissue‐isolated estrogen receptor alpha‐positive ( ER α +) MCF ‐7 human breast cancer xenografts, grown in nude rats maintained on a light/dark cycle of LD 12:12 in which dLEN is present during the dark phase (suppressed endogenous nocturnal melatonin), a significant shortening of tumor latency‐to‐onset, increased tumor metabolism and growth, and complete intrinsic resistance to Dox therapy. Conversely, a LD 12:12 dLEN environment incorporating nocturnal melatonin replacement resulted in significantly lengthened tumor latency‐to‐onset, tumor regression, suppression of nighttime tumor metabolism, and kinase and transcription factor phosphorylation, while Dox sensitivity was completely restored. Melatonin acts as both a tumor metabolic inhibitor and circadian‐regulated kinase inhibitor to reestablish the sensitivity of breast tumors to Dox and drive tumor regression, indicating that dLEN ‐induced circadian disruption of nocturnal melatonin production contributes to a complete loss of tumor sensitivity to Dox chemotherapy." @default.
• W2045987911 created "2016-06-24" @default.
• W2045987911 creator A5003731794 @default.
• W2045987911 creator A5016402426 @default.
• W2045987911 creator A5027252737 @default.
• W2045987911 creator A5037460127 @default.
• W2045987911 creator A5043142422 @default.
• W2045987911 creator A5046305632 @default.
• W2045987911 creator A5065251818 @default.
• W2045987911 creator A5067223991 @default.
• W2045987911 creator A5071281736 @default.
• W2045987911 creator A5078580387 @default.
• W2045987911 creator A5088918381 @default.
• W2045987911 date "2015-04-20" @default.
• W2045987911 modified "2023-10-04" @default.
• W2045987911 title "Doxorubicin resistance in breast cancer is driven by light at night‐induced disruption of the circadian melatonin signal" @default.
• W2045987911 cites W1271389891 @default.
• W2045987911 cites W1499275777 @default.
• W2045987911 cites W1515699320 @default.
• W2045987911 cites W1565610159 @default.
• W2045987911 cites W1964709116 @default.
• W2045987911 cites W1966342316 @default.
• W2045987911 cites W1968973290 @default.
• W2045987911 cites W1976603215 @default.
• W2045987911 cites W1982612741 @default.
• W2045987911 cites W1990614024 @default.
• W2045987911 cites W2006434892 @default.
• W2045987911 cites W2009914667 @default.
• W2045987911 cites W2010183849 @default.
• W2045987911 cites W2013844329 @default.
• W2045987911 cites W2015127357 @default.
• W2045987911 cites W2020709143 @default.
• W2045987911 cites W2028957157 @default.
• W2045987911 cites W2034113803 @default.
• W2045987911 cites W2034564753 @default.
• W2045987911 cites W2035158815 @default.
• W2045987911 cites W2036021808 @default.
• W2045987911 cites W2041339830 @default.
• W2045987911 cites W2049731427 @default.
• W2045987911 cites W2051856872 @default.
• W2045987911 cites W2053785734 @default.
• W2045987911 cites W2056893202 @default.
• W2045987911 cites W2060217203 @default.
• W2045987911 cites W2064854415 @default.
• W2045987911 cites W2069526613 @default.
• W2045987911 cites W2070727232 @default.
• W2045987911 cites W2075816124 @default.
• W2045987911 cites W2082850451 @default.
• W2045987911 cites W2082894007 @default.
• W2045987911 cites W2087366979 @default.
• W2045987911 cites W2092559416 @default.
• W2045987911 cites W2104195539 @default.
• W2045987911 cites W2127480567 @default.
• W2045987911 cites W2139034458 @default.
• W2045987911 cites W2141393790 @default.
• W2045987911 cites W2143225948 @default.
• W2045987911 cites W2144169031 @default.
• W2045987911 cites W2151010413 @default.
• W2045987911 cites W2152868870 @default.
• W2045987911 cites W2158229562 @default.
• W2045987911 cites W2163339619 @default.
• W2045987911 cites W2166021020 @default.
• W2045987911 cites W2340424447 @default.
• W2045987911 cites W2409651531 @default.
• W2045987911 doi "https://doi.org/10.1111/jpi.12239" @default.
• W2045987911 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4490975" @default.
• W2045987911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25857269" @default.
• W2045987911 hasPublicationYear "2015" @default.
• W2045987911 type Work @default.
• W2045987911 sameAs 2045987911 @default.
• W2045987911 citedByCount "84" @default.
• W2045987911 countsByYear W20459879112015 @default.
• W2045987911 countsByYear W20459879112016 @default.
• W2045987911 countsByYear W20459879112017 @default.
• W2045987911 countsByYear W20459879112018 @default.
• W2045987911 countsByYear W20459879112019 @default.
• W2045987911 countsByYear W20459879112020 @default.
• W2045987911 countsByYear W20459879112021 @default.
• W2045987911 countsByYear W20459879112022 @default.
• W2045987911 countsByYear W20459879112023 @default.
• W2045987911 crossrefType "journal-article" @default.
• W2045987911 hasAuthorship W2045987911A5003731794 @default.
• W2045987911 hasAuthorship W2045987911A5016402426 @default.
• W2045987911 hasAuthorship W2045987911A5027252737 @default.
• W2045987911 hasAuthorship W2045987911A5037460127 @default.
• W2045987911 hasAuthorship W2045987911A5043142422 @default.
• W2045987911 hasAuthorship W2045987911A5046305632 @default.
• W2045987911 hasAuthorship W2045987911A5065251818 @default.
• W2045987911 hasAuthorship W2045987911A5067223991 @default.
• W2045987911 hasAuthorship W2045987911A5071281736 @default.
• W2045987911 hasAuthorship W2045987911A5078580387 @default.
• W2045987911 hasAuthorship W2045987911A5088918381 @default.
• W2045987911 hasBestOaLocation W20459879112 @default.
• W2045987911 hasConcept C121446783 @default.
• W2045987911 hasConcept C121608353 @default.
• W2045987911 hasConcept C126322002 @default.
• W2045987911 hasConcept C134018914 @default.
• W2045987911 hasConcept C184235292 @default.

• next